Novartis AG
Methods of treating FGF21-associated disorders
Last updated:
Abstract:
The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human .beta.-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Status:
Grant
Type:
Utility
Filling date:
2 Aug 2016
Issue date:
1 Feb 2022